CANGRELOR TETRASODIUM: 17 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
17
Total FAERS Reports
2 (11.8%)
Deaths Reported
8
Hospitalizations
17
As Primary/Secondary Suspect
7
Life-Threatening
First Report: 20210601 · Latest Report: 20241202
What Are the Most Common CANGRELOR TETRASODIUM Side Effects?
#1 Most Reported
Off label use
11 reports (64.7%)
#2 Most Reported
Vascular stent thrombosis
7 reports (41.2%)
#3 Most Reported
Thrombocytopenia
7 reports (41.2%)
All CANGRELOR TETRASODIUM Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 11 | 64.7% | 0 | 7 |
| Drug interaction | 7 | 41.2% | 0 | 6 |
| Thrombocytopenia | 7 | 41.2% | 0 | 6 |
| Vascular stent thrombosis | 7 | 41.2% | 0 | 6 |
| Acute myocardial infarction | 6 | 35.3% | 0 | 6 |
| Colitis ischaemic | 6 | 35.3% | 0 | 6 |
| Drug level decreased | 6 | 35.3% | 0 | 6 |
| Electrocardiogram st segment elevation | 6 | 35.3% | 0 | 6 |
| Eosinophil cationic protein increased | 6 | 35.3% | 0 | 6 |
| Eosinophilia | 6 | 35.3% | 0 | 6 |
| Erythema | 6 | 35.3% | 0 | 6 |
| Hypersensitivity | 6 | 35.3% | 0 | 6 |
| Hypotension | 6 | 35.3% | 0 | 6 |
| Nausea | 6 | 35.3% | 0 | 6 |
| Rectal haemorrhage | 6 | 35.3% | 0 | 6 |
| Product use in unapproved indication | 5 | 29.4% | 0 | 5 |
Who Reports CANGRELOR TETRASODIUM Side Effects? Age & Gender Data
Gender: 48.5% female, 51.5% male. Average age: 63.8 years. Most reports from: IT. View detailed demographics →
Is CANGRELOR TETRASODIUM Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2021 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 0 |
What Is CANGRELOR TETRASODIUM Used For?
| Indication | Reports |
|---|---|
| Antiplatelet therapy | 10 |
Official FDA Label for CANGRELOR TETRASODIUM
Official prescribing information from the FDA-approved drug label.